These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
601 related articles for article (PubMed ID: 32174262)
21. Long noncoding RNA LINC00885 upregulates NCK1 to promote cell viability and migration of triple-negative breast cancer cells through sponging miR-654-3p. He P; Liu Z; Qi J; Shan J; Sheng J Cancer Biomark; 2024; 39(1):63-78. PubMed ID: 37694355 [TBL] [Abstract][Full Text] [Related]
22. MicroRNA-124-3p.1 promotes cell proliferation through Axin1-dependent Wnt signaling pathway and predicts a poor prognosis of triple-negative breast cancer. Yang W; Cui G; Ding M; Yang M; Dai D J Clin Lab Anal; 2020 Jul; 34(7):e23266. PubMed ID: 32125723 [TBL] [Abstract][Full Text] [Related]
23. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer. Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518 [TBL] [Abstract][Full Text] [Related]
24. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer. Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392 [TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p. Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177 [TBL] [Abstract][Full Text] [Related]
26. Circular RNA dehydrodolichyl diphosphate synthase facilitated triple-negative breast cancer progression via miR-362-3p/DDX5 axis. Cui S; Zhang Y; Xing L; Li R; Piao Y; Liu H Environ Toxicol; 2022 Jun; 37(6):1483-1494. PubMed ID: 35343646 [TBL] [Abstract][Full Text] [Related]
27. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients. Li YY; Zheng XH; Deng AP; Wang Y; Liu J; Zhou Q; Cheng GY; Jiang Q Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10433-10442. PubMed ID: 31841197 [TBL] [Abstract][Full Text] [Related]
28. HIF-1α/Malat1/miR-141 Axis Activates Autophagy to Increase Proliferation, Migration, and Invasion in Triple-negative Breast Cancer. Xu F; Hu Y; Gao J; Wang J; Xie Y; Sun F; Wang L; Miyamoto A; Xia O; Zhang C Curr Cancer Drug Targets; 2023; 23(5):363-378. PubMed ID: 36579395 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA-301b promotes cell proliferation and apoptosis resistance in triple-negative breast cancer by targeting CYLD. Song H; Li D; Wu T; Xie D; Hua K; Hu J; Deng X; Ji C; Deng Y; Fang L BMB Rep; 2018 Nov; 51(11):602-607. PubMed ID: 30269739 [TBL] [Abstract][Full Text] [Related]
30. MiR-296-3p inhibits cell proliferation by the SOX4-Wnt/βcatenin pathway in triple-negative breast cancer. Tian D; Luo L; Wang T; Qiao J J Biosci; 2021; 46():. PubMed ID: 34785625 [TBL] [Abstract][Full Text] [Related]
31. miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer. Ji H; Sang M; Liu F; Ai N; Geng C Pathol Res Pract; 2019 Apr; 215(4):697-704. PubMed ID: 30611621 [TBL] [Abstract][Full Text] [Related]
32. lncRNA GHET1 Promotes the Progression of Triple-Negative Breast Cancer Wang Y; Li C Comput Math Methods Med; 2022; 2022():8366569. PubMed ID: 35509860 [TBL] [Abstract][Full Text] [Related]
33. MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147. Wang C; Xu C; Niu R; Hu G; Gu Z; Zhuang Z BMC Cancer; 2019 Jun; 19(1):577. PubMed ID: 31196010 [TBL] [Abstract][Full Text] [Related]
34. LncRNA LINC00173 enhances triple-negative breast cancer progression by suppressing miR-490-3p expression. Fan H; Yuan J; Li X; Ma Y; Wang X; Xu B; Li X Biomed Pharmacother; 2020 May; 125():109987. PubMed ID: 32058222 [TBL] [Abstract][Full Text] [Related]
35. CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling. Han C; Li X; Fan Q; Liu G; Yin J Aging (Albany NY); 2019 Jul; 11(14):4858-4875. PubMed ID: 31310241 [TBL] [Abstract][Full Text] [Related]
36. miR-122-5p promotes aggression and epithelial-mesenchymal transition in triple-negative breast cancer by suppressing charged multivesicular body protein 3 through mitogen-activated protein kinase signaling. Wang Z; Wang X J Cell Physiol; 2020 Mar; 235(3):2825-2835. PubMed ID: 31541468 [TBL] [Abstract][Full Text] [Related]
37. Down-regulating GRP78 reverses pirarubicin resistance of triple negative breast cancer by miR-495-3p mimics and involves the p-AKT/mTOR pathway. Liu M; Yang J; Lv W; Wang S; Du T; Zhang K; Wu Y; Feng X Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34935899 [TBL] [Abstract][Full Text] [Related]
38. MiR-6838-5p suppresses cell metastasis and the EMT process in triple-negative breast cancer by targeting WNT3A to inhibit the Wnt pathway. Liu G; Wang P; Zhang H J Gene Med; 2019 Dec; 21(12):e3129. PubMed ID: 31693779 [TBL] [Abstract][Full Text] [Related]
39. MiR-212-5p Suppresses the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer by Targeting Prrx2. Lv ZD; Yang DX; Liu XP; Jin LY; Wang XG; Yang ZC; Liu D; Zhao JJ; Kong B; Li FN; Wang HB Cell Physiol Biochem; 2017; 44(5):1785-1795. PubMed ID: 29216628 [TBL] [Abstract][Full Text] [Related]
40. miR-518a-3p Suppresses Triple-Negative Breast Cancer Invasion and Migration Through Regulation of TMEM2. Gan L; Yang H; Xiong Z; Yang Z; Wang T; Lyu G Technol Cancer Res Treat; 2020; 19():1533033820977523. PubMed ID: 33251982 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]